29 results on '"Sinelli M"'
Search Results
2. Hemodynamic evaluation in preterm infants using ultrasonic cardiac output monitor (USCOM)
- Author
-
Doni, D, Faraguna, M, Zannin, E, Rinaldi, A, Cafolla, C, Iozzi, L, Cavalleri, V, Rigotti, C, Sinelli, M, Fedeli, T, Ventura, M, Doni, Daniela, Faraguna, Martha Caterina, Zannin, Emanuela, Rinaldi, Alessandro, Cafolla, Claudia, Iozzi, Lucia, Cavalleri, Valeria, Rigotti, Camilla, Sinelli, Mariateresa, Fedeli, Tiziana, Ventura, Maria Luisa, Doni, D, Faraguna, M, Zannin, E, Rinaldi, A, Cafolla, C, Iozzi, L, Cavalleri, V, Rigotti, C, Sinelli, M, Fedeli, T, Ventura, M, Doni, Daniela, Faraguna, Martha Caterina, Zannin, Emanuela, Rinaldi, Alessandro, Cafolla, Claudia, Iozzi, Lucia, Cavalleri, Valeria, Rigotti, Camilla, Sinelli, Mariateresa, Fedeli, Tiziana, and Ventura, Maria Luisa
- Abstract
We aimed to establish reference ranges for USCOM parameters in preterm infants, determine factors that affect cardiac output, and evaluate the measurement repeatability. This retro-prospective study was performed at Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy. We included infants below 32 weeks of gestational age (GA) and/or 1500 g of birth weight (BW). We excluded infants with congenital heart diseases or hemodynamic instability. Measurements were performed at 3 +/- 1, 7 +/- 2, and 14 +/- 2 postnatal days. We analyzed 204 measurements from 92 patients (median GA = 30.57 weeks, BW = 1360 g). The mean (SD) cardiac output (CO) was 278 (55) ml/min/kg, cardiac index (CI) was 3.1 (0.5) L/min/m2, and systemic vascular resistance (SVRI) was 1292 (294) d*s*cm-5/m2. CO presented a negative correlation with postmenstrual age (PMA), while SVRI presented a positive correlation with PMA. The repeatability coefficient was 31 ml/kg/min (12%). Conclusion: This is the first study describing reference values for USCOM parameters in hemodynamically stable preterm infants and factors affecting their variability. Further studies to investigate the usefulness of USCOM for the longitudinal assessment of patients at risk for cardiovascular instability or monitoring the response to therapies are warranted. What is Known:center dot The ultrasonic cardiac output monitoring (USCOM) has been widely used on adult and pediatric patients and reference ranges for cardiac output (CO) by USCOM have been established in term infants.What is New:center dot We established reference values for USCOM parameters in very preterm and very-low-birth-weight infants; the reference ranges for CO by USCOM in the study population were 198-405 ml/kg/min.center dot CO normalized by body weight presented a significant negative correlation with postmenstrual age (PMA); systemic vascular resistance index presented a significant positive correlation with PMA.
- Published
- 2024
3. Prenatal use of indomethacin for preterm labor and renal function among very low birth weight infants
- Author
-
Sinelli, M, Ornaghi, S, Doni, D, Paterlini, G, Locatelli, A, Bernasconi, D, Vergani, P, Ventura, M, Bernasconi, DP, Ventura, ML, Sinelli, M, Ornaghi, S, Doni, D, Paterlini, G, Locatelli, A, Bernasconi, D, Vergani, P, Ventura, M, Bernasconi, DP, and Ventura, ML
- Abstract
BACKGROUND: Indomethacin is administered as a tocolytic agent for threatening preterm labor <28weeks of gestation. Only a few, not conclusive, studies have investigated its nephrotoxicity in very low birth weight (VLBW) infants. We investigated whether indomethacin increases the incidence of acute kidney injury (AKI) among VLBW infants. METHODS: This is a retrospective study including all VLBW infants born at our center between January 1, 2005, and December 31, 2013. Indomethacin was administered to women with preterm labor and intact membranes. Neonatal AKI was defined according to KDIGO classification. Univariate analyses were performed comparing VLBW infants exposed to and not exposed to indomethacin. In the multivariable model, the association of indomethacin and AKI was adjusted for patent ductus arteriosus, use of nephrotoxic medications, birth weight, and gestational age. RESULTS: Five hundred seventy-five VLBW infants were included, 49 (8.5%) of whom were exposed to indomethacin in utero. The univariate analysis showed that infants exposed to indomethacin had lower birth weight, lower gestational age, and higher incidence of AKI than infants not exposed. The multivariable model adjusted for confounding factors confirmed an increased risk of AKI in relation to gestational age at birth <27 weeks, but not to indomethacin. CONCLUSIONS: Our data suggest that extreme prematurity, but not the use of indomethacin, is associated with AKI.
- Published
- 2024
4. Fatal severe persistent pulmonary hypertension with lung microvasculature parietal hyperplasia in a neonate with congenital cytomegalovirus infection treated in-utero with valacyclovir: A case report
- Author
-
Fernicola, F, Carli, A, Arienti, F, Vasarri, M, Lanteri, L, Scandella, G, Poletti De Chaurand, V, Zicoia, M, Iozzi, L, Gorla, S, Ventura, L, Locatelli, A, Sinelli, M, Ornaghi, S, Vasarri, MV, Ventura, LM, Fernicola, F, Carli, A, Arienti, F, Vasarri, M, Lanteri, L, Scandella, G, Poletti De Chaurand, V, Zicoia, M, Iozzi, L, Gorla, S, Ventura, L, Locatelli, A, Sinelli, M, Ornaghi, S, Vasarri, MV, and Ventura, LM
- Published
- 2024
5. Association of intrauterine growth restriction and low birth weight with acute kidney injury in preterm neonates
- Author
-
Sinelli, M, Zannin, E, Doni, D, Ornaghi, S, Acampora, E, Roncaglia, N, Vergani, P, Ventura, M, Sinelli M., Zannin E., Doni D., Ornaghi S., Acampora E., Roncaglia N., Vergani P., Ventura M. L., Sinelli, M, Zannin, E, Doni, D, Ornaghi, S, Acampora, E, Roncaglia, N, Vergani, P, Ventura, M, Sinelli M., Zannin E., Doni D., Ornaghi S., Acampora E., Roncaglia N., Vergani P., and Ventura M. L.
- Abstract
Background: Preterm birth alters nephrogenesis and reduces the total nephron number. Intrauterine growth restriction (IUGR) seems to worsen nephron loss, but only a few studies have investigated its role in neonatal kidney impairment. We investigated whether IUGR, defined as reduced estimated fetal growth and/or placental flow alterations and low birth weight z-score, increases the risk of developing acute kidney injury (AKI) in very preterm infants. Methods: We performed a retrospective study including infants born with a birth weight (BW) ≤ 1500 g and/or gestational age (GA) ≤ 32 weeks admitted to our center between January 2016 and December 2021. Neonatal AKI was defined according to the neonatal KDIGO classification based on the decline of urine output and/or creatinine elevation. We used multivariable linear regressions to verify the association between AKI and GA, BW z-score, IUGR definition, and hemodynamically significant patent ductus arteriosus (PDA). Results: We included 282 infants in the analysis, with a median (IQR) GA = 29.4 (27.4, 31.3) weeks, BW = 1150 (870, 1360) g, and BW z-score = − 0.57 (− 1.64, 0.25). AKI was diagnosed in 36 (13%) patients, and 58 (21%) had PDA. AKI was significantly associated with BW z-score (beta (std. error) = − 0.08 (0.03), p = 0.008) and severe IUGR (beta (std. error) = 0.21 (0.08), p = 0.009), after adjusting for GA and PDA. Conclusions: Our data suggest that low BW z-score and IUGR could represent adjunctive risk factors for kidney impairment in preterm babies.
- Published
- 2023
6. Danno renale acuto ed encefalopatia ipossico-ischemica
- Author
-
Sinelli, M, Paterlini, G, Ornaghi, S, Tagliabue, P, Sinelli M, Paterlini G, Ornaghi S, Tagliabue P, Sinelli, M, Paterlini, G, Ornaghi, S, Tagliabue, P, Sinelli M, Paterlini G, Ornaghi S, and Tagliabue P
- Published
- 2017
7. Danno renale acuto ed encefalopatia ipossico-ischemica
- Author
-
Sinelli M, Paterlini G, Ornaghi S, Tagliabue P, Sinelli, M, Paterlini, G, Ornaghi, S, and Tagliabue, P
- Subjects
insufficienza renale, encefalopatia, ipossia-ischemia - Published
- 2017
8. Proteomic studies to assess the mechanism of action of the antiproliferative effect of furoxans in smooth muscle cells
- Author
-
Arnaboldi, L., primary, Lombardi, M., additional, Sinelli, M., additional, Rolando, B., additional, Lazzarato, L., additional, Fruttero, R., additional, Gasco, A., additional, and CorsinI, A., additional
- Published
- 2017
- Full Text
- View/download PDF
9. Studies on the mechanism of action of the antiproliferative effect of no-donors furoxans in smooth muscle cells
- Author
-
Arnaboldi, L., primary, Lombardi, M., additional, Sinelli, M., additional, Rolando, B., additional, Lazzarato, L., additional, Fruttero, R., additional, Gasco, A., additional, and Corsini, A., additional
- Published
- 2016
- Full Text
- View/download PDF
10. Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART. The Italian Register for HIV Infection in Children
- Author
-
WRITING COMMITTEE CHIAPPINI, E, Galli, L, Tovo, Pa, Gabiano, C, Lisi, C, Gattinara, Gc, Esposito, S, Viganò, A, Giaquinto, C, Rosso, R, Guarino, A, Osimani, DE MARTINO M. MEMBERS OF THE ITALIAN REGISTER FOR HIV INFECTION IN CHILDREN P., Cordiali, R., DE MATTIA, D., Manzionna, M., DI BARI, C., Ruggeri, M., Masi, M., Miniaci, A., Specchia, F., Ciccia, M., Lanari, M., Baldi, F., Battisti, L., Schumacher, R., Duse, M., Sinelli, M., Bennato, V., Dessì, C., Dedoni, M., Fenu, M. L., Cavallini, R., Anastasio, E., Zicchinella, D., Sticca, M., Pomero, G., Contiero, R., Fiumana, E., Gervaso, P., Gabrielli, G., Braccesi, G., Becherucci, S., DE GAUDIO, M., Innocenti, L., Cecchi, M. T., Ginocchio, F., Nicolini, L. A., Ciravegna, B. W., Cosso, D., Timitilli, A., Stronati, M., Plebani, A., Bojanin, J., Porta, A., Principi, N., Giacomet, V., Bianchi, R., Zuccotti, G. V., Giovannini, M., Ferraris, G., Lipreri, R., MORETTI MILANO, C., Cellini, M., Cano, M. C., Palazzi, G., Bruzzese, E., Giannattazio, A., Tarallo, L., Tancredi, F., D'Elia, R., Rampon, O., DALLE NOGARE, E. R., Sanfilippo, A., Romano, A., Saitta, M., Dodi, I., Barone, A., Consolini, Rita, Legitimo, Annalisa, Magnani, C., Falconieri, P., Fundarò, C., Salvucci, P. VALENTINI S., Casadei, A. M., Bernardi, S., Palma, P., Anzidei, M., Cerilli, S., Ajassa, C., Ganau, A., Cristiano, L., Mazza, A., Gentilini, L., Mignone, F., Versace, A., Antonielli, E., Sovatzis, S., Scolfaro, C., Palomba, E., Portelli, V., Rabusin, M., Pellegatta, A., and Fortunati, P.
- Published
- 2007
11. Cooperative intervention to assist children with HIV-infection in Burkina Faso: The Brescia experience during the pilot phase of the ESTHER Project
- Author
-
Fausti, R, Soncini, E, Ravelli, C, Cattalini, Marco, Sinelli, M, Consolati, V, Pietra, Virginio Antonino, Pignatelli, S, Castelli, Francesco, Notarangelo, Luigi Daniele, and Schumacher, R. F.
- Published
- 2006
12. Intervento di Cooperazione sanitaria per l'assistenza ai bambini affetti da HIV/AIDS in Burkina Faso: l'esperienza della Clinica Pediatrica di Brescia
- Author
-
Fausti, R, Soncini, E, Ravelli, C, Cattalini, Marco, Sinelli, M, Consolati, V, Demartiis, D, Gualeni, G, Marniga, E, Pietra, Virginio Antonino, Pignatelli, S, Castelli, Francesco, Notarangelo, Luigi Daniele, and Schumacher, Rf
- Published
- 2006
13. 1206 Association Between Different Acute Kidney Injury (AKI) Definitions and Mortality in Very Low Birth Weight (VLBW) Infants
- Author
-
Sinelli, M., primary, Paterlini, G., additional, Grillo, P., additional, and Tagliabue, P., additional
- Published
- 2012
- Full Text
- View/download PDF
14. Surge protection with automatic reset
- Author
-
Chan, R. B and Sinelli, M. C
- Subjects
Electronic Components And Circuits - Abstract
Circuit turns power off automatically when surge occurs and restores power when voltage returns to normal. Transmitters and other equipment are protected in electrically noisy environments; however, if three transient overvoltages (or continuous overvoltage) are sensed within 3.2 seconds, circuit turns power supply off permanently since serious failure may have occurred.
- Published
- 1980
15. Severe neonatal renal failure after maternal use of angiotensin II type I receptor antagonists.
- Author
-
Sinelli, M. T., Cattarelli, D., Cortinovis, S., Maroccolo, D., and Chirico, G.
- Abstract
The article describes the case of severe renal failure in a 36-week old baby girl whose mother had taken Olmesartan for hypertension during her last month of pregnancy. The baby died of cardio-circulatory failure 45 days after her birth with kidneys showing severe tubular dysgenesis. Also included is information on sartans as treatment for arterial hypertension and role of renin-angiotensin components in kidney development. The study concludes that exposure to sartans during the last month of pregnancy can cause congenital malformations, renal impairment, and fetal or neo-natal death.
- Published
- 2008
16. Association of intrauterine growth restriction and low birth weight with acute kidney injury in preterm neonates
- Author
-
Mariateresa Sinelli, Emanuela Zannin, Daniela Doni, Sara Ornaghi, Eleonora Acampora, Nadia Roncaglia, Patrizia Vergani, Maria Luisa Ventura, Sinelli, M, Zannin, E, Doni, D, Ornaghi, S, Acampora, E, Roncaglia, N, Vergani, P, and Ventura, M
- Subjects
Preterm newborn ,Nephrology ,Pediatrics, Perinatology and Child Health ,Intrauterine growth restriction ,Acute kidney injury - Abstract
Background: Preterm birth alters nephrogenesis and reduces the total nephron number. Intrauterine growth restriction (IUGR) seems to worsen nephron loss, but only a few studies have investigated its role in neonatal kidney impairment. We investigated whether IUGR, defined as reduced estimated fetal growth and/or placental flow alterations and low birth weight z-score, increases the risk of developing acute kidney injury (AKI) in very preterm infants. Methods: We performed a retrospective study including infants born with a birth weight (BW) ≤ 1500 g and/or gestational age (GA) ≤ 32 weeks admitted to our center between January 2016 and December 2021. Neonatal AKI was defined according to the neonatal KDIGO classification based on the decline of urine output and/or creatinine elevation. We used multivariable linear regressions to verify the association between AKI and GA, BW z-score, IUGR definition, and hemodynamically significant patent ductus arteriosus (PDA). Results: We included 282 infants in the analysis, with a median (IQR) GA = 29.4 (27.4, 31.3) weeks, BW = 1150 (870, 1360) g, and BW z-score = − 0.57 (− 1.64, 0.25). AKI was diagnosed in 36 (13%) patients, and 58 (21%) had PDA. AKI was significantly associated with BW z-score (beta (std. error) = − 0.08 (0.03), p = 0.008) and severe IUGR (beta (std. error) = 0.21 (0.08), p = 0.009), after adjusting for GA and PDA. Conclusions: Our data suggest that low BW z-score and IUGR could represent adjunctive risk factors for kidney impairment in preterm babies.
- Published
- 2023
17. Useful Clinical Criteria for Identifying Neonates with Congenital Cytomegalovirus Infection at Birth in the Context of an Expanded Targeted Screening Program.
- Author
-
Poletti de Chaurand V, Scandella G, Zicoia M, Arienti F, Fernicola F, Lanteri L, Guglielmi D, Carli A, Vasarri MV, Iozzi L, Cavallero A, Malandrin SMI, Locatelli A, Ventura ML, Sinelli M, and Ornaghi S
- Subjects
- Humans, Infant, Newborn, Female, Pregnancy, Italy epidemiology, Male, Hearing Loss, Sensorineural virology, Hearing Loss, Sensorineural diagnosis, Prevalence, Cytomegalovirus Infections congenital, Cytomegalovirus Infections diagnosis, Neonatal Screening methods, Cytomegalovirus genetics, Cytomegalovirus isolation & purification, Pregnancy Complications, Infectious diagnosis, Pregnancy Complications, Infectious virology
- Abstract
Cytomegalovirus (CMV) is the leading infectious cause of brain defects and neurological dysfunctions, including sensorineural hearing loss (SNHL). Targeted screening in neonates failing the hearing screen is currently recommended in Italy according to national guidelines. However, SNHL may not be present at birth; also, congenital CMV (cCMV) may manifest with subtle signs other than SNHL. Therefore, the inclusion of additional criteria for cCMV screening appears clinically valuable. Starting January 2021, we have implemented expanded targeted cCMV screening at our center, with testing in case of maternal CMV infection during pregnancy, inadequate antenatal care, maternal HIV infection or immunosuppression, birthweight and/or head circumference < 10th centile, failed hearing screen, and prematurity. During the first three years of use of this program (2021-2023), 940 (12.3%) of 7651 live-born infants were tested. The most common indication was birthweight < 10th centile (n = 633, 67.3%). Eleven neonates were diagnosed as congenitally infected, for a prevalence of 1.17% (95%CI 0.48-1.86) on tested neonates and of 0.14% (95%CI 0.06-0.23) on live-born infants. None of the cCMV-infected newborns had a failed hearing screen as a testing indication. Implementation of an expanded cCMV screening program appears feasible and of clinical value.
- Published
- 2024
- Full Text
- View/download PDF
18. Hemodynamic evaluation in preterm infants using ultrasonic cardiac output monitor (USCOM).
- Author
-
Doni D, Faraguna MC, Zannin E, Rinaldi A, Cafolla C, Iozzi L, Cavalleri V, Rigotti C, Sinelli M, Fedeli T, and Ventura ML
- Subjects
- Humans, Infant, Newborn, Male, Female, Reference Values, Prospective Studies, Retrospective Studies, Hemodynamics physiology, Reproducibility of Results, Gestational Age, Monitoring, Physiologic methods, Vascular Resistance physiology, Cardiac Output physiology, Infant, Premature
- Abstract
We aimed to establish reference ranges for USCOM parameters in preterm infants, determine factors that affect cardiac output, and evaluate the measurement repeatability. This retro-prospective study was performed at Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy. We included infants below 32 weeks of gestational age (GA) and/or 1500 g of birth weight (BW). We excluded infants with congenital heart diseases or hemodynamic instability. Measurements were performed at 3 ± 1, 7 ± 2, and 14 ± 2 postnatal days. We analyzed 204 measurements from 92 patients (median GA = 30.57 weeks, BW = 1360 g). The mean (SD) cardiac output (CO) was 278 (55) ml/min/kg, cardiac index (CI) was 3.1 (0.5) L/min/m
2 , and systemic vascular resistance (SVRI) was 1292 (294) d*s*cm-5 /m2 . CO presented a negative correlation with postmenstrual age (PMA), while SVRI presented a positive correlation with PMA. The repeatability coefficient was 31 ml/kg/min (12%). Conclusion: This is the first study describing reference values for USCOM parameters in hemodynamically stable preterm infants and factors affecting their variability. Further studies to investigate the usefulness of USCOM for the longitudinal assessment of patients at risk for cardiovascular instability or monitoring the response to therapies are warranted. What is Known: • The ultrasonic cardiac output monitoring (USCOM) has been widely used on adult and pediatric patients and reference ranges for cardiac output (CO) by USCOM have been established in term infants. What is New: • We established reference values for USCOM parameters in very preterm and very-low-birth-weight infants; the reference ranges for CO by USCOM in the study population were 198-405 ml/kg/min. • CO normalized by body weight presented a significant negative correlation with postmenstrual age (PMA); systemic vascular resistance index presented a significant positive correlation with PMA., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)- Published
- 2024
- Full Text
- View/download PDF
19. SARS-CoV-2 perinatal transmission and neonatal outcomes across four different waves of COVID-19 pandemic: A nationwide prospective cohort study from the Italian Society of Neonatology.
- Author
-
Pugni L, Crippa BL, Raimondi F, Vento G, Mangili G, Coscia A, Artieri G, Ronchi A, Ventura ML, Lago P, Pietrasanta C, Crimi R, Bonfante G, Perrone S, Boncompagni A, Solinas A, Agosti M, Poggi C, Falcone A, Pagliotta C, Gianotti D, Gottardi G, Paviotti G, Allodi A, Maffei G, Proto A, Travierso A, Salomè S, Costa S, Ferrari S, Peila C, Sinelli M, Fanelli F, Giordano L, Saruggia M, Capasso L, Spada E, Gizzi C, Orfeo L, and Mosca F
- Subjects
- Infant, Newborn, Female, Pregnancy, Humans, Infant, SARS-CoV-2, Pandemics, Prospective Studies, Cohort Studies, Infectious Disease Transmission, Vertical, Italy epidemiology, Mothers, COVID-19 epidemiology, Neonatology, Pregnancy Complications, Infectious epidemiology
- Abstract
Objectives: To describe how SARS-CoV-2 infection at the time of delivery affected maternal and neonatal outcomes across four major waves of the COVID-19 pandemic in Italy., Methods: This is a large, prospective, nationwide cohort study collecting maternal and neonatal data in case of maternal peripartum SARS-CoV-2 infection between February 2020 and March 2022. Data were stratified across the four observed pandemic waves., Results: Among 5201 COVID-19-positive mothers, the risk of being symptomatic at delivery was significantly higher in the first and third waves (20.8-20.8%) than in the second and fourth (13.2-12.2%). Among their 5284 neonates, the risk of prematurity (gestational age <37 weeks) was significantly higher in the first and third waves (15.6-12.5%). The risk of intrauterine transmission was always very low, while the risk of postnatal transmission during rooming-in was higher and peaked at 4.5% during the fourth wave. A total of 80% of positive neonates were asymptomatic., Conclusion: The risk of adverse maternal and neonatal outcomes was significantly higher during the first and third waves, dominated by unsequenced variants and the Delta variant, respectively. Postnatal transmission accounted for most neonatal infections and was more frequent during the Omicron period. However, the paucity of symptoms in infected neonates should lead us not to separate the dyad., Competing Interests: Declaration of Competing Interest All authors have no competing interests to declare., (Copyright © 2023. Published by Elsevier Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
20. Fatal severe persistent pulmonary hypertension with lung microvasculature parietal hyperplasia in a neonate with congenital cytomegalovirus infection treated in-utero with valacyclovir: A case report.
- Author
-
Fernicola F, Carli A, Arienti F, Viola Vasarri M, Lanteri L, Scandella G, Poletti De Chaurand V, Zicoia M, Iozzi L, Gorla S, Luisa Ventura M, Locatelli A, Sinelli M, and Ornaghi S
- Subjects
- Infant, Newborn, Humans, Valacyclovir therapeutic use, Hyperplasia, Lung diagnostic imaging, Microvessels, Antiviral Agents therapeutic use, Hypertension, Pulmonary drug therapy, Hypertension, Pulmonary etiology, Cytomegalovirus Infections complications, Cytomegalovirus Infections drug therapy
- Abstract
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Published
- 2024
- Full Text
- View/download PDF
21. Prenatal use of indomethacin for preterm labor and renal function among very low birth weight infants.
- Author
-
Sinelli M, Ornaghi S, Doni D, Paterlini G, Locatelli A, Bernasconi DP, Vergani P, and Ventura ML
- Subjects
- Infant, Newborn, Pregnancy, Humans, Female, Infant, Indomethacin adverse effects, Retrospective Studies, Birth Weight, Infant, Very Low Birth Weight, Kidney, Obstetric Labor, Premature chemically induced, Obstetric Labor, Premature drug therapy, Acute Kidney Injury chemically induced, Acute Kidney Injury epidemiology, Acute Kidney Injury drug therapy
- Abstract
Background: Indomethacin is administered as a tocolytic agent for threatening preterm labor <28weeks of gestation. Only a few, not conclusive, studies have investigated its nephrotoxicity in very low birth weight (VLBW) infants. We investigated whether indomethacin increases the incidence of acute kidney injury (AKI) among VLBW infants., Methods: This is a retrospective study including all VLBW infants born at our center between January 1, 2005, and December 31, 2013. Indomethacin was administered to women with preterm labor and intact membranes. Neonatal AKI was defined according to KDIGO classification. Univariate analyses were performed comparing VLBW infants exposed to and not exposed to indomethacin. In the multivariable model, the association of indomethacin and AKI was adjusted for patent ductus arteriosus, use of nephrotoxic medications, birth weight, and gestational age., Results: Five hundred seventy-five VLBW infants were included, 49 (8.5%) of whom were exposed to indomethacin in utero. The univariate analysis showed that infants exposed to indomethacin had lower birth weight, lower gestational age, and higher incidence of AKI than infants not exposed. The multivariable model adjusted for confounding factors confirmed an increased risk of AKI in relation to gestational age at birth <27 weeks, but not to indomethacin., Conclusions: Our data suggest that extreme prematurity, but not the use of indomethacin, is associated with AKI.
- Published
- 2024
- Full Text
- View/download PDF
22. Letter to Editor: Asymptomatic CMV infection at birth following maternal infection, valacyclovir treatment, and a subsequent negative amniocentesis.
- Author
-
Fernicola F, Carli A, Arienti F, Vasarri MV, Lanteri L, Scandella G, De Chaurand VP, Zicoia M, Iozzi L, Ventura ML, Sinelli M, Locatelli A, and Ornaghi S
- Subjects
- Pregnancy, Infant, Newborn, Female, Humans, Valacyclovir therapeutic use, Amniocentesis, Antiviral Agents therapeutic use, Infectious Disease Transmission, Vertical prevention & control, Cytomegalovirus Infections diagnosis, Cytomegalovirus Infections drug therapy, Pregnancy Complications, Infectious diagnosis, Pregnancy Complications, Infectious drug therapy
- Abstract
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Published
- 2024
- Full Text
- View/download PDF
23. Early Postnatal Infection of Neonates Born to Mothers Infected by SARS-CoV-2 Omicron Variant.
- Author
-
Pietrasanta C, Ronchi A, Agosti M, Mangili G, Sinelli M, Ghirardello S, Barachetti R, Crimi R, Fasolato V, Martinelli S, Bellan C, Crippa B, Artieri G, Perniciaro S, Saruggia M, Ventura ML, Garofoli F, Pagliotta C, Uceda Renteria SC, Piralla A, Bergami F, Morandi G, Proto A, Pontiggia F, Risso FM, Bossi A, Ferrari S, Cavalleri V, Servi P, Castiglione A, Spada E, Ceriotti F, Baldanti F, Mosca F, and Pugni L
- Subjects
- Infant, Infant, Newborn, Female, Humans, Pregnancy, Mothers, Prospective Studies, RNA, Viral, SARS-CoV-2 genetics, Infectious Disease Transmission, Vertical, COVID-19, Pregnancy Complications, Infectious diagnosis, Pregnancy Complications, Infectious epidemiology
- Abstract
Objectives: To evaluate the rate of postnatal infection during the first month of life in neonates born to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive mothers during the predominant circulation of the omicron (B.1.1.529) variant., Methods: This prospective, 10-center study enrolled mothers infected by SARS-CoV-2 at delivery and their infants, if both were eligible for rooming-in, between December 2021 and March 2022. Neonates were screened for SARS-CoV-2 RNA at 1 day of life (DOL), 2 to 3 DOL, before discharge, and twice after hospital discharge. Mother-infant dyads were managed under a standardized protocol to minimize the risk of viral transmission. Sequencing data in the study area were obtained from the Italian Coronavirus Disease 2019 Genomic platform. Neonates were included in the final analysis if they were born when the omicron variant represented >90% of isolates., Results: Eighty-two percent (302/366) of mothers had an asymptomatic SARS-CoV-2 infection. Among 368 neonates, 1 was considered infected in utero (0.3%), whereas the postnatal infection rate during virtually exclusive circulation of the omicron variant was 12.1%. Among neonates infected after birth, 48.6% became positive during the follow-up period. Most positive cases at follow-up were detected concurrently with the peak of coronavirus disease 2019 cases in Italy. Ninety-seven percent of the infected neonates were asymptomatic., Conclusions: The risk of early postnatal infection by the SARS-CoV-2 omicron variant is higher than that reported for previously circulating variants. However, protected rooming-in practice should still be encouraged given the paucity of symptoms in infected neonates., (Copyright © 2023 by the American Academy of Pediatrics.)
- Published
- 2023
- Full Text
- View/download PDF
24. Association of intrauterine growth restriction and low birth weight with acute kidney injury in preterm neonates.
- Author
-
Sinelli M, Zannin E, Doni D, Ornaghi S, Acampora E, Roncaglia N, Vergani P, and Ventura ML
- Subjects
- Female, Humans, Infant, Newborn, Pregnancy, Birth Weight, Ductus Arteriosus, Patent complications, Fetal Growth Retardation, Gestational Age, Infant, Premature, Infant, Very Low Birth Weight, Placenta, Retrospective Studies, Acute Kidney Injury etiology, Acute Kidney Injury complications, Premature Birth
- Abstract
Background: Preterm birth alters nephrogenesis and reduces the total nephron number. Intrauterine growth restriction (IUGR) seems to worsen nephron loss, but only a few studies have investigated its role in neonatal kidney impairment. We investigated whether IUGR, defined as reduced estimated fetal growth and/or placental flow alterations and low birth weight z-score, increases the risk of developing acute kidney injury (AKI) in very preterm infants., Methods: We performed a retrospective study including infants born with a birth weight (BW) ≤ 1500 g and/or gestational age (GA) ≤ 32 weeks admitted to our center between January 2016 and December 2021. Neonatal AKI was defined according to the neonatal KDIGO classification based on the decline of urine output and/or creatinine elevation. We used multivariable linear regressions to verify the association between AKI and GA, BW z-score, IUGR definition, and hemodynamically significant patent ductus arteriosus (PDA)., Results: We included 282 infants in the analysis, with a median (IQR) GA = 29.4 (27.4, 31.3) weeks, BW = 1150 (870, 1360) g, and BW z-score = - 0.57 (- 1.64, 0.25). AKI was diagnosed in 36 (13%) patients, and 58 (21%) had PDA. AKI was significantly associated with BW z-score (beta (std. error) = - 0.08 (0.03), p = 0.008) and severe IUGR (beta (std. error) = 0.21 (0.08), p = 0.009), after adjusting for GA and PDA., Conclusions: Our data suggest that low BW z-score and IUGR could represent adjunctive risk factors for kidney impairment in preterm babies. A higher resolution version of the Graphical abstract is available as Supplementary information., (© 2023. The Author(s), under exclusive licence to International Pediatric Nephrology Association.)
- Published
- 2023
- Full Text
- View/download PDF
25. Proteomics Studies Suggest That Nitric Oxide Donor Furoxans Inhibit In Vitro Vascular Smooth Muscle Cell Proliferation by Nitric Oxide-Independent Mechanisms.
- Author
-
Lazzarato L, Bianchi L, Andolfo A, Granata A, Lombardi M, Sinelli M, Rolando B, Carini M, Corsini A, Fruttero R, and Arnaboldi L
- Subjects
- Endothelial Cells metabolism, Muscle, Smooth, Vascular, Proteomics, Cell Proliferation, Cells, Cultured, Myocytes, Smooth Muscle, Nitric Oxide Donors pharmacology, Nitric Oxide Donors metabolism, Nitric Oxide metabolism
- Abstract
Physiologically, smooth muscle cells (SMC) and nitric oxide (NO) produced by endothelial cells strictly cooperate to maintain vasal homeostasis. In atherosclerosis, where this equilibrium is altered, molecules providing exogenous NO and able to inhibit SMC proliferation may represent valuable antiatherosclerotic agents. Searching for dual antiproliferative and NO-donor molecules, we found that furoxans significantly decreased SMC proliferation in vitro, albeit with different potencies. We therefore assessed whether this property is dependent on their thiol-induced ring opening. Indeed, while furazans (analogues unable to release NO) are not effective, furoxans' inhibitory potency parallels with the electron-attractor capacity of the group in 3 of the ring, making this effect tunable. To demonstrate whether their specific block on G1-S phase could be NO-dependent, we supplemented SMCs with furoxans and inhibitors of GMP- and/or of the polyamine pathway, which regulate NO-induced SMC proliferation, but they failed in preventing the antiproliferative effect. To find the real mechanism of this property, our proteomics studies revealed that eleven cellular proteins (with SUMO1 being central) and networks involved in cell homeostasis/proliferation are modulated by furoxans, probably by interaction with adducts generated after degradation. Altogether, thanks to their dual effect and pharmacological flexibility, furoxans may be evaluated in the future as antiatherosclerotic molecules.
- Published
- 2023
- Full Text
- View/download PDF
26. Retrospective study of tumors from cattle slaughtered in Lombardy (Italy): preliminary evaluation on the establishment of a bovine cancer registry.
- Author
-
Cappelleri A, Minoli L, Pigoli C, Costa A, Zaghini L, Bassanini L, Sinelli M, Perri M, Luini MV, Tagliabue G, Gibelli LR, and Scanziani E
- Subjects
- Cattle, Humans, Animals, Retrospective Studies, Registries, Animals, Domestic, Neoplasms epidemiology, Neoplasms veterinary, Cattle Diseases epidemiology, Cattle Diseases pathology
- Abstract
Forty‑one tumors were detected in a population of 1,649,003 cattle slaughtered in 4 abattoirs in Lombardy over a 5‑year period, for an overall prevalence of 2.5 tumors per 100,000 cattle. Tumors were classified according to the WHO histological classification of tumors of domestic animals. Alimentary and hemopoietic systems were commonly affected with 9 cases each. Other affected sites were the respiratory (n = 3), urinary (n = 2), endocrine (n = 2), musculoskeletal (n = 2), nervous (n = 1), and cardiovascular (n = 1) systems. The peritoneum was affected by 6 cases, while the primary location of 3 tumors of the connective tissues and 3 metastatic carcinomas was unidentified. Liver tumors and mesotheliomas, for which environmental risk factors are well‑known in humans, were common, as well as tumors typically encountered in pediatric human patients (tumors of mesenchymal tissues, pulmonary blastomas and nephroblastomas). These findings suggest the useful role of bovines as sentinel and model for human carcinogenesis. Our study indicates that the establishment of a bovine cancer registry in Lombardy is feasible considering its potential contribution to understanding the role of environmental risk factors in the genesis of tumors in animals and humans.
- Published
- 2022
- Full Text
- View/download PDF
27. P53 induces senescence in the unstable progeny of aneuploid cells.
- Author
-
Giam M, Wong CK, Low JS, Sinelli M, Dreesen O, and Rancati G
- Subjects
- Cell Cycle Checkpoints genetics, Cell Proliferation genetics, Cell Transformation, Neoplastic genetics, Cell Transformation, Neoplastic metabolism, Chromosomal Instability genetics, Chromosome Segregation genetics, Gene Knockdown Techniques, HEK293 Cells, Humans, Karyotype, Tumor Suppressor Protein p53 genetics, Aneuploidy, Cellular Senescence genetics, Epithelial Cells metabolism, Retinal Pigment Epithelium cytology, Tumor Suppressor Protein p53 metabolism
- Abstract
Aneuploidy is the condition of having an imbalanced karyotype, which is associated with tumor initiation, evolution, and acquisition of drug-resistant features, possibly by generating heterogeneous populations of cells with distinct genotypes and phenotypes. Multicellular eukaryotes have therefore evolved a range of extrinsic and cell-autonomous mechanisms for restraining proliferation of aneuploid cells, including activation of the tumor suppressor protein p53. However, accumulating evidence indicates that a subset of aneuploid cells can escape p53-mediated growth restriction and continue proliferating in vitro . Here we show that such aneuploid cell lines display a robust modal karyotype and low frequency of chromosomal aberrations despite ongoing chromosome instability. Indeed, while these aneuploid cells are able to survive for extended periods in vitro , their chromosomally unstable progeny remain subject to p53-induced senescence and growth restriction, leading to subsequent elimination from the aneuploid pool. This mechanism helps maintain low levels of heterogeneity in aneuploid populations and may prevent detrimental evolutionary processes such as cancer progression and development of drug resistance.
- Published
- 2020
- Full Text
- View/download PDF
28. Early Neonatal SARS-CoV-2 Infection Manifesting With Hypoxemia Requiring Respiratory Support.
- Author
-
Sinelli M, Paterlini G, Citterio M, Di Marco A, Fedeli T, and Ventura ML
- Subjects
- COVID-19, Coronavirus Infections therapy, Humans, Hypoxia therapy, Infant, Newborn, Male, Pandemics, Pneumonia, Viral therapy, SARS-CoV-2, Betacoronavirus, Coronavirus Infections complications, Coronavirus Infections diagnostic imaging, Hypoxia complications, Hypoxia diagnostic imaging, Pneumonia, Viral complications, Pneumonia, Viral diagnostic imaging, Respiration, Artificial methods
- Abstract
We describe a case of neonatal SARS-CoV-2 infection, in an infant diagnosed 3 days after birth, and manifesting with silent hypoxemia, requiring respiratory support., Competing Interests: POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose., (Copyright © 2020 by the American Academy of Pediatrics.)
- Published
- 2020
- Full Text
- View/download PDF
29. Severe neonatal renal failure after maternal use of angiotensin II type I receptor antagonists.
- Author
-
Sinelli MT, Cattarelli D, Cortinovis S, Maroccolo D, and Chirico G
- Subjects
- Adult, Apgar Score, Birth Weight, Fatal Outcome, Female, Humans, Infant, Newborn, Kidney Tubules, Proximal pathology, Pregnancy, Renal Insufficiency pathology, Angiotensin II Type 1 Receptor Blockers adverse effects, Fetus drug effects, Hypertension drug therapy, Imidazoles adverse effects, Pregnancy Complications, Cardiovascular drug therapy, Renal Insufficiency chemically induced, Tetrazoles adverse effects
- Abstract
Sartans are selective type 1 angiotensin II receptor antagonists that are used for treatment of arterial hypertension. We report a case of severe renal failure required dialysis after the use of olmesartan in the last month of pregnancy. Exposure to sartans during the last period of gestation seems to be associated with high risk of congenital malformations. It is important to stress that the use of these drugs during pregnancy must be avoided, especially in the third trimester.
- Published
- 2008
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.